Re: Richard J. Sylvester, Maurizio A. Brausi, Wim J. Kirkels, et al Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guerin, and Bacillus Calmette-Guerin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder. Eur Urol 2010;57:766-73 Reply

Richard J. Sylvester; Maurizio A. Brausi; Ziya Kirkali; Theo M. de Reijke

doi:https://doi.org/10.1016/j.eururo.2010.02.038

Re: Richard J. Sylvester, Maurizio A. Brausi, Wim J. Kirkels, et al Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guerin, and Bacillus Calmette-Guerin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder. Eur Urol 2010;57:766-73 Reply

Richard J. Sylvester, Maurizio A. Brausi, Ziya Kirkali, Theo M. de Reijke

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Pages (from-to)	E58-E59
Journal	European Urology
Volume	57
Issue number	6
DOIs	https://doi.org/10.1016/j.eururo.2010.02.038
Publication status	Published - 2010

Access to Document

https://doi.org/10.1016/j.eururo.2010.02.038

Cite this

Sylvester, R. J., Brausi, M. A., Kirkali, Z., & de Reijke, T. M. (2010). Re: Richard J. Sylvester, Maurizio A. Brausi, Wim J. Kirkels, et al Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guerin, and Bacillus Calmette-Guerin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder. Eur Urol 2010;57:766-73 Reply. European Urology, 57(6), E58-E59. https://doi.org/10.1016/j.eururo.2010.02.038

Sylvester, Richard J. ; Brausi, Maurizio A. ; Kirkali, Ziya et al. / Re: Richard J. Sylvester, Maurizio A. Brausi, Wim J. Kirkels, et al Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guerin, and Bacillus Calmette-Guerin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder. Eur Urol 2010;57:766-73 Reply. In: European Urology. 2010 ; Vol. 57, No. 6. pp. E58-E59.

@article{ba17be82de2c436091084d5f1f396b48,

title = "Re: Richard J. Sylvester, Maurizio A. Brausi, Wim J. Kirkels, et al Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guerin, and Bacillus Calmette-Guerin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder. Eur Urol 2010;57:766-73 Reply",

author = "Sylvester, {Richard J.} and Brausi, {Maurizio A.} and Ziya Kirkali and {de Reijke}, {Theo M.}",

year = "2010",

doi = "https://doi.org/10.1016/j.eururo.2010.02.038",

language = "English",

volume = "57",

pages = "E58--E59",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "6",

}

Sylvester, RJ, Brausi, MA, Kirkali, Z & de Reijke, TM 2010, 'Re: Richard J. Sylvester, Maurizio A. Brausi, Wim J. Kirkels, et al Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guerin, and Bacillus Calmette-Guerin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder. Eur Urol 2010;57:766-73 Reply', European Urology, vol. 57, no. 6, pp. E58-E59. https://doi.org/10.1016/j.eururo.2010.02.038

Re: Richard J. Sylvester, Maurizio A. Brausi, Wim J. Kirkels, et al Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guerin, and Bacillus Calmette-Guerin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder. Eur Urol 2010;57:766-73 Reply. / Sylvester, Richard J.; Brausi, Maurizio A.; Kirkali, Ziya et al.
In: European Urology, Vol. 57, No. 6, 2010, p. E58-E59.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Re: Richard J. Sylvester, Maurizio A. Brausi, Wim J. Kirkels, et al Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guerin, and Bacillus Calmette-Guerin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder. Eur Urol 2010;57:766-73 Reply

AU - Sylvester, Richard J.

AU - Brausi, Maurizio A.

AU - Kirkali, Ziya

AU - de Reijke, Theo M.

PY - 2010

Y1 - 2010

U2 - https://doi.org/10.1016/j.eururo.2010.02.038

DO - https://doi.org/10.1016/j.eururo.2010.02.038

M3 - Comment/Letter to the editor

SN - 0302-2838

VL - 57

SP - E58-E59

JO - European Urology

JF - European Urology

IS - 6

ER -

Sylvester RJ, Brausi MA, Kirkali Z, de Reijke TM. Re: Richard J. Sylvester, Maurizio A. Brausi, Wim J. Kirkels, et al Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guerin, and Bacillus Calmette-Guerin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder. Eur Urol 2010;57:766-73 Reply. European Urology. 2010;57(6):E58-E59. doi: https://doi.org/10.1016/j.eururo.2010.02.038